DORIA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.771
EU - Europa 4.570
AS - Asia 3.754
SA - Sud America 36
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 22
Totale 40.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.726
CN - Cina 1.790
IT - Italia 1.624
SG - Singapore 1.576
FI - Finlandia 697
DE - Germania 553
FR - Francia 383
SE - Svezia 378
UA - Ucraina 317
GB - Regno Unito 310
VN - Vietnam 165
IN - India 100
NL - Olanda 92
IE - Irlanda 62
HK - Hong Kong 40
CA - Canada 36
ES - Italia 28
EU - Europa 22
RU - Federazione Russa 21
BR - Brasile 16
JP - Giappone 16
PE - Perù 16
AU - Australia 15
GR - Grecia 15
TR - Turchia 15
PL - Polonia 14
CH - Svizzera 11
RO - Romania 10
EG - Egitto 9
CZ - Repubblica Ceca 7
MX - Messico 7
NZ - Nuova Zelanda 7
TW - Taiwan 7
ZA - Sudafrica 7
IR - Iran 6
LU - Lussemburgo 6
PK - Pakistan 6
SA - Arabia Saudita 6
HU - Ungheria 5
RS - Serbia 5
AT - Austria 4
BE - Belgio 4
KR - Corea 4
BD - Bangladesh 3
BY - Bielorussia 3
ID - Indonesia 3
MY - Malesia 3
NO - Norvegia 3
SM - San Marino 3
TH - Thailandia 3
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MK - Macedonia 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
DK - Danimarca 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LV - Lettonia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
ZM - Zambia 1
Totale 40.201
Salva come PNG Salva come JPEG
Città #
Fairfield 5.429
Woodbridge 3.039
Houston 2.504
Chandler 2.291
Ashburn 2.221
Cambridge 1.901
Seattle 1.891
Ann Arbor 1.889
Wilmington 1.765
Jacksonville 1.565
Singapore 1.248
Boardman 821
Princeton 817
San Diego 555
Santa Clara 540
Medford 392
Beijing 373
Des Moines 366
Nanjing 309
Padova 275
Helsinki 266
Roxbury 200
Dong Ket 163
Milan 114
New York 100
Hebei 94
Shenyang 91
Rome 89
Nanchang 78
Guangzhou 77
London 70
Redwood City 68
Jinan 65
Dearborn 64
Norwalk 62
Changsha 59
Jiaxing 58
Ogden 47
Dublin 44
Tianjin 39
Florence 37
Shanghai 33
Los Angeles 29
Lappeenranta 28
Kilburn 27
Falls Church 26
Hefei 26
Hong Kong 26
Kharkiv 26
Verona 24
Bologna 22
Kunming 22
Bari 21
Genoa 21
Washington 21
Amsterdam 20
Munich 20
Venice 18
Naples 17
Zhengzhou 17
Borås 16
Cagliari 15
Rockville 15
Trois-Rivières 15
Arezzo 14
Las Vegas 14
Ningbo 14
Nürnberg 14
Chicago 13
Haikou 13
Paris 13
Turin 13
Frankfurt am Main 12
Madrid 12
Acton 10
Dallas 10
Ferrara 10
Indiana 10
Udine 10
Düsseldorf 9
Hangzhou 9
Islington 9
Lucca 9
Pasian di Prato 9
Prescot 9
São Paulo 9
Trento 9
Treviso 9
Vicenza 9
Athens 8
Brescia 8
Miami 8
Phoenix 8
Tappahannock 8
Trieste 8
Tübingen 8
Wandsworth 8
Gdansk 7
Groningen 7
Hounslow 7
Totale 32.938
Salva come PNG Salva come JPEG
Nome #
Gli anticorpi miosite specifici e miosite associati nelle miopatie infiammatorie idiopatiche: studio sierologico di 46 pazienti. 200
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 186
Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus. 177
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): A new SLE continuous measure with high sensitivity for changes in disease activity 166
Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study 164
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 164
Pregnancy and vasculitis: A systematic review of the literature. 162
Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. 161
Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. 156
Advances in the Diagnosis and Classification of Systemic Lupus Erythematosus 154
Subclinical myopathy in patients affected with newly diagnosed colorectal cancer at clinical onset of disease: evidence from skeletal muscle biopsies. 148
Impact of hypertension on vascular remodeling in patients with psoriatic arthritis 148
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 146
Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age? 144
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 142
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 141
Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission 140
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study 138
Antigen preparation for immunological studies in systemic autoimmune diseases. 138
Impact of hypertension on vascular remodeling in patients with psoriatic arthritis 138
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. 136
PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis. 135
Autoinflammation and autoimmunity: Bridging the divide. 134
The kaleidoscope of glucocorticoid effects on immune system 133
Antigen preparation for immunological studies in systemic autoimmune diseases 132
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis. 130
Influence of coping skills on health-related quality of life in patients with systemic lupus erythematosus 128
Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity 128
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression 127
A case of progressive multifocal leukoencephalopathy in a lupus patient treated with belimumab--comments on article by Fredericks et al. 127
Overlap connective tissue disease syndromes. 126
OxLDL/β2GPI-anti-oxLDL/β2GPI complex and atherosclerosis in SLE patients. 125
Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study. 125
17-β-estradiol affects BLyS serum levels and the nephritogenic autoantibody network accelerating glomerulonephritis in NZB/WF1 mice. 125
Infections and autoimmunity: the multifaceted relationship. 124
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. 123
IL-12 and IL-23/Th17 axis in systemic lupus erythematosus 123
SERPINB3, apoptosis and autoimmunity 122
Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: A literature review 122
Therapy of scleroderma renal crisis: State of the art 122
The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients 119
Clinical and pathologic considerations of the qualitative and quantitative aspects of lupus nephritogenic autoantibodies: A comprehensive review 118
Grade and location of power Doppler are predictive of damage progression in rheumatoid arthritis patients in clinical remission by anti-tumour necrosis factor α 118
Medium-/long-term effects of a specific exercise protocol combined with patient education on spine mobility, chronic fatigue, pain, aerobic fitness and level of disability in fibromyalgia. 116
Success and failure of biological treatment in systemic lupus erythematosus: A critical analysis 116
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay 115
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs 114
Polymyositis, dermatomyositis and malignancy: A further intriguing link. 114
Pregnancy in rare autoimmune rheumatic diseases: UCTD, MCTD, myositis, systemic vasculitis and Bechet disease 114
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 114
The olfactory function is impaired in patients with idiopathic inflammatory myopathies. 114
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 114
SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients 114
The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy. 113
Antibodies to muscle and ganglionic acetylcholine receptors (AchR) in celiac disease. 113
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases. 113
Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus 111
Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies 111
Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis. 110
New therapeutic strategies in systemic lupus erythematosus management 110
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups 109
PRESENCE, GRADE AND LOCATION OF POWER DOPPLER PREDICT PROGRESSION OF RADIOGRAPHIC DAMAGE IN TNFα BLOCKER INDUCED CLINICAL REMISSION IN RHEUMATOID ARTHRITIS PATIENTS 109
A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome 108
Breast prostheses and connective tissue disease (CTD): myth or reality? 108
The clinical features, diagnosis and classification of dermatomyositis. 108
Commercial blot assays in the diagnosis of systemic rheumatic diseases 107
Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity-a Comprehensive Review. 107
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes 107
Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: A newsworthy association 107
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 106
Clinical implications of autoantibody screening in patients with autoimmune myositis. 106
Rheumatic and autoimmune thyroid disorders: a causal or casual relationship? 106
LIPOPROTEIN COMPOSITIONAL ABNORMALITIES IN TYPE 1 (INSULIN-DEPENDENT) DIABETIC PATIENTS 105
Self-reported flares are predictors of radiographic progression in rheumatoid arthritis patients in 28-joint disease activity score remission: a 24-month observational study 105
Can we manage lupus nephritis without chronic corticosteroids administration? 105
Clinical outcomes and predictors of maternal and fetal complications in pregnancies of patients with systemic lupus erythematosus 105
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. 105
Adalimumab in psoriatic arthritis 104
Cell stress-response in skeletal muscle myofibers 104
Prognosis of scleroderma renal crisis: a long-term observational study. 104
The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses 103
The periprosthetic capsule and connective tissue diseases: a piece in the puzzle of autoimmune / autoinflammatory syndrome induced by adjuvants. 102
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevation 102
Myositis autoantibodies and clinical phenotypes 102
Primary prevention of systemic lupus erythematosus. 102
2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus 102
Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients 102
Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice. 102
Seltene autoimmune rheumatische erkrankungen in der schwangerschaft: systemische sklerose, dermato-polymyositis und vaskulitiden. 100
Cutting Edge Issues in Polymyositis 100
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature. 100
Thalidomide neurotoxicity: prospective study in patients with lupus erythematosus 100
Squamous cell carcinoma antigen-IgM (SCCA-IgM) is associated with interstitial lung disease in systemic sclerosis 100
Ketone bodies increase glomerular filtration rate in normal man and in patients with Type 1 (insulin-dependent) diabetes mellitus 100
null 99
Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment 99
2nd Conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005 98
Polymyositis-dermatomyositis and infections. 98
Overlap connective tissue disease syndromes. 98
Parotid, breast, and fascial involvement in a patient who fulfilled the ACR criteria for Churg-Strauss syndrome. 98
Totale 12.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.370
article - articoli 151.154
book - libri 555
conference - conferenze 0
curatela - curatele 0
other - altro 116
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.070
Totale 310.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.652 0 0 0 0 812 628 780 891 830 812 466 433
2020/20216.596 244 522 218 487 212 488 195 566 931 653 673 1.407
2021/20226.764 171 711 752 549 281 497 260 758 334 263 630 1.558
2022/20234.900 1.199 463 98 514 747 599 32 347 545 62 221 73
2023/20243.206 116 348 316 248 218 311 218 137 253 159 409 473
2024/20253.984 109 923 678 581 1.693 0 0 0 0 0 0 0
Totale 40.752